Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

923 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hematopoietic stem cell transplantation for myelodysplastic syndrome.
Parmar S, de Lima M. Parmar S, et al. Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S37-44. doi: 10.1016/j.bbmt.2009.10.018. Epub 2009 Oct 24. Biol Blood Marrow Transplant. 2010. PMID: 19857589 Review.
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
de Lima M, van Besien KW, Giralt SA, Khouri IF, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Korbling M, Champlin RE. de Lima M, et al. Bone Marrow Transplant. 1997 Jan;19(2):121-7. doi: 10.1038/sj.bmt.1700614. Bone Marrow Transplant. 1997. PMID: 9116608
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
van Besien KW, de Lima M, Giralt SA, Moore DF Jr, Khouri IF, Rondón G, Mehra R, Andersson BS, Dyer C, Cleary K, Przepiorka D, Gajewski JL, Champlin RE. van Besien KW, et al. Bone Marrow Transplant. 1997 May;19(10):977-82. doi: 10.1038/sj.bmt.1700781. Bone Marrow Transplant. 1997. PMID: 9169641
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Popat U, Przepiork D, Champlin R, Pugh W, Amin K, Mehra R, Rodriguez J, Giralt S, Romaguera J, Rodriguez A, Preti A, Andersson B, Khouri I, Claxton D, de Lima M, Donato M, Anderlini P, Gajewski J, Cabanillas F, van Besien K. Popat U, et al. J Clin Oncol. 1998 Jan;16(1):63-9. doi: 10.1200/JCO.1998.16.1.63. J Clin Oncol. 1998. PMID: 9440724
Chronic lymphocytic leukemia in the young patient.
de Lima M, O'Brien S, Lerner S, Keating MJ. de Lima M, et al. Semin Oncol. 1998 Feb;25(1):107-16. Semin Oncol. 1998. PMID: 9482532 Review.
Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemia.
DeLima M, Albitar M, O'Brien S, Pierce S, Kantarjian H, Andreeff M, Fayad L, Keating M, Estey E. DeLima M, et al. Am J Med. 1998 Mar;104(3):246-51. doi: 10.1016/s0002-9343(98)00032-1. Am J Med. 1998. PMID: 9552087
PURPOSE: To analyze the rates of concordance in the diagnosis of various hematological malignancies among patients referred to a tertiary cancer center, comparing the referring diagnosis with the final diagnosis at the M.D. ...The concordance rate was 76% in the 100 cases …
PURPOSE: To analyze the rates of concordance in the diagnosis of various hematological malignancies among patients referred to a tertiary ca …
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
de Lima M, van Besien K, Gajewski J, Khouri I, Andersson B, Korbling M, Champlin R, Giralt S. de Lima M, et al. Bone Marrow Transplant. 2000 Aug;26(3):333-8. doi: 10.1038/sj.bmt.1702521. Bone Marrow Transplant. 2000. PMID: 10967575 Clinical Trial.
Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.
de Lima M, Bonamino M, Vasconcelos Z, Colares M, Diamond H, Zalcberg I, Tavares R, Lerner D, Byington R, Bouzas L, da Matta J, Andrade C, Carvalho L, Pires V, Barone B, Maciel C, Tabak D. de Lima M, et al. Bone Marrow Transplant. 2001 Jan;27(1):73-8. doi: 10.1038/sj.bmt.1702726. Bone Marrow Transplant. 2001. PMID: 11244440
We investigated the use of 'prophylactic' donor lymphocyte infusions (DLI) containing 1 x 107 CD3+ cells, given at 30, 60 and 90 days post-allogeneic blood and marrow transplantation (BMT), following conditioning with fludarabine 30 mg/m(2)/4 days and melphalan 70 mg/m
We investigated the use of 'prophylactic' donor lymphocyte infusions (DLI) containing 1 x 107 CD3+ cells, given at 30, 60 and 90 days post-a …
Unrelated donor hematopoietic transplantation.
de Lima M, Champlin R. de Lima M, et al. Rev Clin Exp Hematol. 2001 Jun;5(2):100-34. doi: 10.1046/j.1468-0734.2001.00035.x. Rev Clin Exp Hematol. 2001. PMID: 11486651 Review.
923 results
Jump to page
Feedback